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Background:  A small proportion of patients with hypertrophic cardiomyopathy (HCM) experience sudden cardiac death (SCD) despite the 
absence of traditional risk factors. Therefore, additional predictors of SCD need to be identified. Delayed contrast enhancement (DCE) on cardiac 
magnetic resonance imaging (MRI) has emerged as a useful adjunct to current risk stratification schemes. However, published studies have 
demonstrated conflicting results.
Methods:  Pubmed, Cochrane, Google Scholar and Web of Science Search databases were searched through October, 2011 using the following 
terms: Magnetic resonance imaging, Hypertrophic Cardiomyopathy, Sudden cardiac death, ventricular fibrillation / tachycardia, and implantable 
defibrillator therapy. Meta-analysis was performed following the MOOSE recommendations using a random effects model.
Results:  A total of 969 abstracts and 23 full text articles were reviewed; 6 studies with 1226 qualified for inclusion. The summary Odds ratio 
for clinical VT/VF, appropriate defibrillator therapy or SCD was 1.68 (0.85-3.34; p=0.14) (Figure2). There was no significant publication bias. As 
sensitivity analysis revealed that exclusion of one study with 108 patients resulted in statistically significant increase in Odds ratio to 2.91 (1.22-
6.95; p=0.01).
Conclusion:  Based on this analysis, DCE on cardiac MRI does not predict the occurrence of clinically relevant VT/VF or SCD though this needs to 
be interpreted with caution in light of the sensitivity analysis.
